| The Movement Disorders Division | Madden Center of Excellence for Parkinson's Disease | HDSA Center of Excellence for Huntington's Disease | Other Movement Disorders |
Male and female volunteers at least 30 years of age with advanced Parkinson’s disease who are on levodopa/carbidopa therapy may be eligible for a research study. This is a study of an investigational medication that is not approved by the Food and Drug Administration (FDA), and is considered an experimental drug for the treatment of Parkinson's disease.
This study will involve approximately 560 patients at approximately 76 sites in the United States and Canada. Seven outpatient visits are planned and participation may last up to 20 weeks. If you are eligible for the study, study medication and physician visits will be provided at no cost to you.
For more information, please call Angie at (614) 292-8607 or email campbell-9@medctr.osu.edu
The Movement Disorders Division
371 McCampbell Hall
1581 Dodd Drive
Columbus, OH 43210
(614) 688-4048
371 McCampbell Hall
1581 Dodd Drive
Columbus, OH 43210
(614) 688-4048